title: [Drug-induced disseminated lung diseases].
abstract: Disseminated pulmonary diseases sensu stricto are interstitial lung disorders, pulmonary edema, diffuse pulmonary bleeding as well as bronchiolitis obliterans and thrombo-embolic disorders. Three important pathogenetic mechanisms are direct toxicity, allergy/immunology and idiosyncrasy; however, unfrequently essential elements of pathogenesis are unknown. The multitude of potential noxious agents implies that the clinician principally has to consider the possibility of drug-toxicity in all cases of disseminated pulmonary diseases. In order to give a complete presentation summaries organized as tables could not be avoid. The most sensible measure for disseminated lung diseases is the functional parameter DLCO; it is more sensible than the conventional X-ray. The drug of choice for a treatment are corticosteroids.
authors.affiliation: Abteilung für Pneumologie, Johann-Wolfgang-Goethe-Universität Frankfurt/Main.
authors.forename: J
authors.initials: J
authors.lastname: Meier-Sydow
authors.forename: H
authors.initials: H
authors.lastname: Kronenberger
mesh_terms: D004342:Drug Hypersensitivity / Q000175:diagnosis / Q000209:etiology*; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D008168:Lung / Q000187:drug effects; D011658:Pulmonary Fibrosis / Q000139:chemically induced* / Q000175:diagnosis
vernacular_title: Arzneimittelverursachte disseminierte Lungenerkrankungen.